Combined biopsy method could improve prostate cancer diagnosis

The study, recently published in the New England Journal of Medicine, combined biopsy methods with the aim of improving prostate cancer diagnosis. The method combined the current primary diagnostic approach, systematic biopsy, with MRI-targeted biopsy.“Prostate cancer has been one of the only solid tumors diagnosed by performing systematic biopsies ‘blind’ to the cancer’s location. For decades this has led to the overdiagnosis and subsequent unnecessary treatment of non-lethal cancers, as well as to missing aggressive high-grade cancers and their opportunity for cure,” commented Peter Pinto (National Cancer Institute, NCI; MD, USA). Systematic biopsies use a non-targeted method of taking systematically...